IP Library Patent Application 16284878
Patent Application
App. No. 16/284,878

Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/284,878
Abstract

The invention relates to multipotential expanded mesenchymal precursor progeny (MEMP's), characterised by the early developmental markers STRO-1 bri and ALP. The present invention also relates to methods for producing MEMP's and to uses of MEMP's for therapeutic applications.

Claims (13)

1 - 55 . (canceled)

56 . A composition comprising a cultured or expanded cell population wherein at least 10% of the total cell population are expanded multipotential MPCs that have the phenotype STRO-1 bright , ALP − and are also positive for one or more of the markers Ki67, CD44, CD49c/CD29, VLA-3 or α3β1, and wherein the composition further comprises STRO-1 dim cells wherein the STRO-1 dim cells are committed to a lineage of tissue or cell type selected from the group consisting of neural tissue, fat, cartilage, skeletal muscle, cardiac muscle, epithelial tissue, tendon, ligament, odnotoblast, pericyte, smooth muscle, glial tissue, vascular tissue, endothelial tissue, haematopoietic tissue, hepatic tissue and renal tissue.

57 . The composition of claim 56 wherein at least 20% of the total cell population are expanded multipotential MPCs that have the phenotype STRO-1 bright , ALP − and are also positive for one or more of the markers Ki67, CD44, CD49c/CD29, VLA-3 or α3β1.

58 . The composition of claim 56 wherein at least 50% of the total cell population are expanded multipotential MPCs that have the phenotype STRO-1 bright , ALP − and are also positive for one or more of the markers Ki67, CD44, CD49c/CD29, VLA-3 or α3β1.

59 . The composition of claim 56 wherein the population comprises at least 5×10 6 cells.

60 . The composition of claim 57 wherein the population comprises at least 5×10 6 cells.

61 . The composition of claim 58 wherein the population comprises at least 5×10 6 cells.

62 . The composition of claim 56 wherein the population comprises at least 10 7 cells.

63 . The composition of claim 57 wherein the population comprises at least 10 7 cells.

64 . The composition of claim 58 wherein the population comprises at least 10 7 cells.

65 . The composition of claim 56 wherein the population comprises at least 10 9 cells.

66 . The composition of claim 57 wherein the population comprises at least 10 9 cells.

67 . The composition of claim 58 wherein the population comprises at least 10 9 cells.

Assignments (2)
CHANGE OF NAME Recorded Mar 26, 2019
From: ANGIOBLAST SYSTEMS, INC.
To: MESOBLAST, INC.
Reel/Frame 048701/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2019
From: GRONTHOS, STAN; ZANNETTINO, ANDREW CHRISTOPHER WILLIAM
To: ANGIOBLAST SYSTEMS, INC.
Reel/Frame 048574/0185 →